E
WVE icon

Ergoteles’s Wave Life Sciences WVE Stock Holding History

Ergoteles’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-20,900
Closed -$76.1K – 863
2023
Q2 		$76.1K Buy
+20,900
New +$84.4K ﹤0.01% 931
2023
Q1 		– Sell
-44,820
Closed -$314K – 1804
2022
Q4 		$314K Sell
44,820
-119,488
-73% -$551K 0.01% 894
2022
Q3 		$593K Sell
164,308
-31,187
-16% -$103K 0.02% 692
2022
Q2 		$635K Buy
+195,495
New +$376K 0.02% 733

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Ergoteles's WVE Position: Q3 2023 in Review

Ergoteles sold out of Wave Life Sciences (WVE) in Q3 2023, closing a stake of 20,900 shares — an estimated $76.1K sold.

Ergoteles first reported a position in WVE in Q2 2022 and held it in 4 quarters. The position peaked at $635K in Q2 2022. 85 funds tracked by Wall St. Rank hold WVE as of Q3 2023.

  • Ergoteles reported no remaining Wave Life Sciences position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 20,900 Wave Life Sciences shares in Q3 2023, an estimated $76.1K.
  • Ergoteles first reported a position in Wave Life Sciences in Q2 2022 and held it in 4 quarters.
  • Ergoteles's Wave Life Sciences position peaked at $635K in Q2 2022.
  • 85 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.